Clinical Trial Update: Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing combined intravitreal bevacizumab and fasudil versus bevacizumab alone for macular edema due to retinal vein occlusion; phases 2 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Bevacizumab (bevacizumab)
• fasudil (fasudil)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Retinal Vein Occlusion | Phase 2, Phase 3 | Status: UNKNOWN